Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Long-Term Lithium Treatment Increases cPLA(2) and iPLA(2) Activity in Cultured Cortical and Hippocampal Neurons

Full text
Author(s):
De-Paula, Vanessa de Jesus [1] ; Kerr, Daniel Shikanai [1] ; Fabiano de Carvalho, Marilia Palma [1] ; Schaeffer, Evelin Lisete [1] ; Talib, Leda Leme [1] ; Gattaz, Wagner Farid [1] ; Forlenza, Orestes Vicente [1]
Total Authors: 7
Affiliation:
[1] Univ Sao Paulo, Dept & Inst Psychiat, Fac Med, Lab Neurosci LIM 27, BR-05403010 Sao Paulo - Brazil
Total Affiliations: 1
Document type: Journal article
Source: Molecules; v. 20, n. 11, p. 19878-19885, NOV 2015.
Web of Science Citations: 6
Abstract

Background: Experimental evidence supports the neuroprotective properties of lithium, with implications for the treatment and prevention of dementia and other neurodegenerative disorders. Lithium modulates critical intracellular pathways related to neurotrophic support, inflammatory response, autophagy and apoptosis. There is additional evidence indicating that lithium may also affect membrane homeostasis. Objective: To investigate the effect of lithium on cytosolic phospholipase A(2) (PLA(2)) activity, a key player on membrane phospholipid turnover which has been found to be reduced in blood and brain tissue of patients with Alzheimer's disease (AD). Methods: Primary cultures of cortical and hippocampal neurons were treated for 7 days with different concentrations of lithium chloride (0.02 mM, 0.2 mM and 2 mM). A radio-enzymatic assay was used to determine the total activity of PLA(2) and two PLA(2) subtypes: cytosolic calcium-dependent (cPLA(2)); and calcium-independent (iPLA(2)). Results: cPLA(2) activity increased by 82% (0.02 mM; p = 0.05) and 26% (0.2 mM; p = 0.04) in cortical neurons and by 61% (0.2 mM; p = 0.03) and 57% (2 mM; p = 0.04) in hippocampal neurons. iPLA(2) activity was increased by 7% (0.2 mM; p = 0.04) and 13% (2 mM; p = 0.05) in cortical neurons and by 141% (0.02 mM; p = 0.0198) in hippocampal neurons. Conclusion: long-term lithium treatment increases membrane phospholipid metabolism in neurons through the activation of total, c- and iPLA(2). This effect is more prominent at sub-therapeutic concentrations of lithium, and the activation of distinct cytosolic PLA(2) subtypes is tissue specific, i.e., iPLA(2) in hippocampal neurons, and cPLA(2) in cortical neurons. Because PLA(2) activities are reported to be reduced in Alzheimer's disease (AD) and bipolar disorder (BD), the present findings provide a possible mechanism by which long-term lithium treatment may be useful in the prevention of the disease. (AU)

FAPESP's process: 09/52825-8 - Neurobiology of Alzheimer's disease: risk markers, prognosis and therapeutic response
Grantee:Wagner Farid Gattaz
Support type: Research Projects - Thematic Grants
FAPESP's process: 11/19892-3 - Effects of lithium on the expression and activity of the enzymes Phospholipase A2 and glycogen synthase kinase 3B and its relation to the phosphorylation state of Tau protein
Grantee:Vanessa de Jesus Rodrigues de Paula
Support type: Scholarships in Brazil - Doctorate